Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by langostaon Nov 16, 2021 10:29am
704 Views
Post# 34131531

RE:RE:RE:RE:RE:News out:Trikoka Gone and

RE:RE:RE:RE:RE:News out:Trikoka Gone andSo Dr Vera took over  3 weeks ago.

Effective October 25, 2021, Dr. Vera Madzarevic, Ph.D. will assume the role of Director of Clinical Development and Quality Assurance reporting to Dr. Mandel.

Dr. Vera M. Madzarevic is a published author and Clinical Scientist as well as a clinical research professional with a demonstrated history of effectively working with the pharmaceutical and medical device industries, as well as academia. Her experience includes leadership in new business development (medical device and medical software development quality management, pharmaceuticals, diagnostic systems) as well as Global organization and oversight of clinical research. Her experience includes QA and regulatory strategies; effective oversight to ensure regulatory compliance to GCP/ICH, GLP, ISO 13485:2016, etc.; International clinical trials management and oversight; Global submission oversight and management (drugs and medical devices) Expert in Clinical Trials, QA/RA, Clinical Monitoring, Good Clinical Practice (GCP), Clinical Trial Management System (CTMS), and Biotechnology among others.
 
Vera's educational background includes a PhD in Pharmacy and Biochemistry, and a Post-doctoral fellowship focused in Molecular Biology/Biochemistry from University of Toronto. Also acts as Expert witness/consultant in litigation as well as European Union (EU) scientific expert/reviewer. Dr. Madzarevic developed one of the most comprehensive programs in Clinical Research Professional Training in Canada and the US. Vera is also a mom of three great kids!!!
 


<< Previous
Bullboard Posts
Next >>